Beijing Chunlizhengda Medical Instruments Co Ltd (688236) — Tangible Net Worth Ratio
Beijing Chunlizhengda Medical Instruments Co Ltd (688236) has a Tangible Net Worth Ratio of 95.9% as of September 2025. This metric is calculated by deducting intangible assets (CN¥121.66 Million) from net assets (CN¥2.99 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 688236 net assets growth trend to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Beijing Chunlizhengda Medical Instruments Co Ltd Tangible Net Worth Ratio (2012–2024)
This chart shows how Beijing Chunlizhengda Medical Instruments Co Ltd's Tangible Net Worth Ratio has changed across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 95.9%, reflecting net assets of CN¥2.99 Billion with intangible assets of CN¥121.66 Million CNY. For live market cap and overall valuation, see Beijing Chunlizhengda Medical Instrument market capitalisation.
Annual Tangible Net Worth Ratio for Beijing Chunlizhengda Medical Instruments Co Ltd (2012–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Beijing Chunlizhengda Medical Instruments Co Ltd from 2012 to 2024, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore 688236 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 95.5% | CN¥2.82 Billion | CN¥127.57 Million | CN¥3.47 Billion | ▲ +0.2 pp |
| 2023 | 95.3% | CN¥2.88 Billion | CN¥136.27 Million | CN¥3.65 Billion | ▲ +0.3 pp |
| 2022 | 94.9% | CN¥2.72 Billion | CN¥138.17 Million | CN¥3.41 Billion | ▲ +0.3 pp |
| 2021 | 94.7% | CN¥2.47 Billion | CN¥131.97 Million | CN¥3.00 Billion | ▲ +4.1 pp |
| 2020 | 90.6% | CN¥1.08 Billion | CN¥101.49 Million | CN¥1.54 Billion | ▲ +3.4 pp |
| 2019 | 87.2% | CN¥806.59 Million | CN¥103.16 Million | CN¥1.21 Billion | ▼ -7.5 pp |
| 2018 | 94.7% | CN¥628.14 Million | CN¥33.11 Million | CN¥814.74 Million | ▲ +0.9 pp |
| 2017 | 93.8% | CN¥538.47 Million | CN¥33.13 Million | CN¥633.66 Million | ▲ +0.9 pp |
| 2016 | 93.0% | CN¥480.91 Million | CN¥33.89 Million | CN¥540.13 Million | ▲ +1.1 pp |
| 2015 | 91.9% | CN¥423.56 Million | CN¥34.46 Million | CN¥478.04 Million | ▲ +9.0 pp |
| 2014 | 82.9% | CN¥205.92 Million | CN¥35.28 Million | CN¥239.86 Million | ▲ +2.9 pp |
| 2013 | 80.0% | CN¥179.89 Million | CN¥36.06 Million | CN¥200.63 Million | ▲ +1.2 pp |
| 2012 | 78.7% | CN¥173.17 Million | CN¥36.87 Million | CN¥187.51 Million | — |